Paraoxonase 1 protects macrophages from atherogenicity of a specific triglyceride isolated from human carotid lesion

Free Radical Biology and Medicine

Volumn 51, Issue 1, 2011, Pages 234-242

  Tavori, Hagai ^a,b,c   Aviram, Michael ^c   Khatib, Soliman ^a,b   Musa, Ramadan ^a,b   Mannheim, Dalit ^d   Karmeli, Ron ^d   Vaya, Jacob ^a,b  

^a MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^b TEL HAI COLLEGE   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

^d CARMEL MEDICAL CENTER   (Israel)

Author keywords

Atherosclerosis; Carotid lesion; Free radicals; Oxidative stress; Paraoxonase 1; Triglyceride

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; LINOLEIC ACID; OLEIC ACID; OXIDIZING AGENT; PALMITIC ACID; REACTIVE OXYGEN METABOLITE; RECOMBINANT ENZYME; RECOMBINANT PARAOXONASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTERY LESION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOACCUMULATION; CAROTID ARTERY; CELL PROTECTION; CONTROLLED STUDY; MACROPHAGE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL;

ANIMALS; ARTERIOSCLEROSIS; ARYLDIALKYLPHOSPHATASE; CAROTID ARTERY DISEASES; HUMANS; LIPID PEROXIDES; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MITOCHONDRIA; NADPH OXIDASE; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TRIGLYCERIDES;

EID: 79957945207     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.03.041     Document Type: Article

References (44)

1. B. Mackness, R. Hunt, P.N. Durrington, and M.I. Mackness Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis Arterioscler. Thromb. Vasc. Biol. 17 1997 1233 1238 (Pubitemid 27329844)
2. H. Tavori, M. Aviram, S. Khatib, R. Musa, S. Nitecki, A. Hoffman, and J. Vaya Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects Free Radic. Biol. Med. 46 2009 607 615
3. H. Tavori, M. Aviram, S. Khatib, R. Musa, D. Mannheim, R. Karmeli, and J. Vaya Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284 Free Radic. Biol. Med. 1 2010 148 156
4. H.C. Gooding, and S.D. de Ferranti Cardiovascular risk assessment and cholesterol management in adolescents: getting to the heart of the matter Curr. Opin. Pediatr. 22 2010 398 404
5. H.W. Breuer Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin Curr. Med. Res. Opin. 17 2001 60 73
6. A. Zernecke, and C. Weber Inflammatory mediators in atherosclerotic vascular disease Basic Res. Cardiol. 100 2005 93 101 (Pubitemid 40361602)
7. J. Labreuche, D. Deplanque, P.J. Touboul, E. Bruckert, and P. Amarenco Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis: systematic review and meta-regression analysis Atherosclerosis 212 2010 9 15
8. A. Aronis, Z. Madar, and O. Tirosh Lipotoxic effects of triacylglycerols in J774.2 macrophages Nutrition 24 2008 167 176
9. A. Aronis, Z. Madar, and O. Tirosh Mechanism underlying oxidative stress-mediated lipotoxicity: exposure of J774.2 macrophages to triacylglycerols facilitates mitochondrial reactive oxygen species production and cellular necrosis Free Radic. Biol. Med. 38 2005 1221 1230 (Pubitemid 40445539)
10. M. Aviram, M. Kaplan, M. Rosenblat, and B. Fuhrman Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development Handb. Exp. Pharmacol. 170 2005 263 300
11. M. Aviram Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants Eur. J. Clin. Chem. Clin. Biochem. 34 1996 599 608 (Pubitemid 26293746)
12. M. Aviram Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins Antioxid. Redox Signal. 1 1999 585 594 (Pubitemid 129628320)
13. O. Rozenberg, M. Rosenblat, R. Coleman, D.M. Shih, and M. Aviram Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice Free Radic. Biol. Med. 34 2003 774 784 (Pubitemid 36288542)
14. B. Fuhrman, M. Shiner, N. Volkova, and M. Aviram Cell-induced copper ion-mediated low-density lipoprotein oxidation increases during in vivo monocyte-to-macrophage differentiation Free Radic. Biol. Med. 37 2004 259 271 (Pubitemid 38760262)
15. S. Billecke, D. Draganov, R. Counsell, P. Stetson, C. Watson, C. Hsu, and B.N. La Du Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters Drug Metab. Dispos. 28 2000 1335 1342
16. D.I. Draganov Lactonases with organophosphatase activity: structural and evolutionary perspectives Chem. Biol. Interact. 187 2010 370 372
17. H. Tavori, S. Khatib, M. Aviram, and J. Vaya Characterization of the PON1 active site using modeling simulation, in relation to PON1 lactonase activity Bioorg. Med. Chem. 16 2008 7504 7509
18. M. Aviram, E. Hardak, J. Vaya, S. Mahmood, S. Milo, A. Hoffman, S. Billicke, D. Draganov, and M. Rosenblat Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities Circulation 101 2000 2510 2517 (Pubitemid 30366256)
19. M. Aviram, M. Rosenblat, C.L. Bisgaier, R.S. Newton, S.L. Primo-Parmo, and B.N. La Du Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase J. Clin. Invest. 101 1998 1581 1590 (Pubitemid 28198486)
20. B. Mackness, R. Quarck, W. Verreth, M. Mackness, and P. Holvoet Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome Arterioscler. Thromb. Vasc. Biol. 26 2006 1545 1550 (Pubitemid 44288981)
21. D.M. Shih, C. Welch, and A.J. Lusis New insights into atherosclerosis from studies with mouse models Mol. Med. Today 1 1995 364 372
22. M. Rosenblat, J. Vaya, D. Shih, and M. Aviram Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine Atherosclerosis 179 2005 69 77 (Pubitemid 40249787)
23. M. Efrat, and M. Aviram Macrophage paraoxonase 1 (PON1) binding sites Biochem. Biophys. Res. Commun. 376 2008 105 110
24. S.P. Deakin, S. Bioletto, M.L. Bochaton-Piallat, and R.W. James HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress Free Radic. Biol. Med. 50 2011 102 109
25. J. Marsillach, J. Camps, R. Beltran-Debon, A. Rull, G. Aragones, C. Maestre-Martinez, F. Sabench, M. Hernandez, D.D. Castillo, J. Joven, M. Mackness, and B. Mackness Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques Eur. J. Clin. Invest. 41 2011 308 314
26. A. Szuchman, M. Aviram, K. Soliman, S. Tamir, and J. Vaya Exogenous N-linoleoyl tyrosine marker as a tool for the characterization of cellular oxidative stress in macrophages Free Radic. Res. 40 2006 41 52 (Pubitemid 43023784)
27. S. Keidar, J. Attias, R. Heinrich, R. Coleman, and M. Aviram Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis Atherosclerosis 146 1999 249 257 (Pubitemid 29418056)
28. E. Marchesi, C. Rota, Y.C. Fann, C.F. Chignell, and R.P. Mason Photoreduction of the fluorescent dye 2′-7′-dichlorofluorescein: a spin trapping and direct electron spin resonance study with implications for oxidative stress measurements Free Radic. Biol. Med. 26 1999 148 161 (Pubitemid 29001502)
29. A. Aronis, M. Aharoni-Simon, Z. Madar, and O. Tirosh Triacylglycerol- induced impairment in mitochondrial biogenesis and function in J774.2 and mouse peritoneal macrophage foam cells Arch. Biochem. Biophys. 492 2009 74 81
30. M. Aviram, and J. Vaya Markers for low-density lipoprotein oxidation Methods Enzymol. 335 2001 244 256 (Pubitemid 32507242)
31. M. el-Saadani, H. Esterbauer, M. el-Sayed, M. Goher, A.Y. Nassar, and G. Jurgens A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent J. Lipid Res. 30 1989 627 630 (Pubitemid 19107750)
32. A. Aharoni, L. Gaidukov, S. Yagur, L. Toker, I. Silman, and D.S. Tawfik Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization Proc. Natl. Acad. Sci. U. S. A. 101 2004 482 487 (Pubitemid 38084662)
33. B. Fuhrman, N. Volkova, and M. Aviram Postprandial serum triacylglycerols and oxidative stress in mice after consumption of fish oil, soy oil or olive oil: possible role for paraoxonase-1 triacylglycerol lipase-like activity Nutrition 22 2006 922 930 (Pubitemid 44234010)
34. A.J. Lusis Atherosclerosis Nature 407 2000 233 241
35. N. Stadler, N. Stanley, S. Heeneman, V. Vacata, M.J. Daemen, P.G. Bannon, J. Waltenberger, and M.J. Davies Accumulation of zinc in human atherosclerotic lesions correlates with calcium levels but does not protect against protein oxidation Arterioscler. Thromb. Vasc. Biol. 28 2008 1024 1030 (Pubitemid 351544123)
36. M. Aviram, I. Maor, S. Keidar, T. Hayek, J. Oiknine, Y. Bar-El, Z. Adler, V. Kertzman, and S. Milo Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated Biochem. Biophys. Res. Commun. 216 1995 501 513
37. J. Vaya, W. Song, S. Khatib, G. Geng, and H.M. Schipper Effects of heme oxygenase-1 expression on sterol homeostasis in rat astroglia Free Radic. Biol. Med. 42 2007 864 871 (Pubitemid 46274172)
38. R. Stocker, and J.F. Keaney Jr. Role of oxidative modifications in atherosclerosis Physiol. Rev. 84 2004 1381 1478 (Pubitemid 39302636)
39. M. Aarnes, S. Schonberg, and V. Grill Fatty acids potentiate interleukin-1β toxicity in the β-cell line INS-1E Biochem. Biophys. Res. Commun. 296 2002 189 193 (Pubitemid 35002077)
40. L.L. Listenberger, D.S. Ory, and J.E. Schaffer Palmitate-induced apoptosis can occur through a ceramide-independent pathway J. Biol. Chem. 276 2001 14890 14895
41. I. Maestre, J. Jordan, S. Calvo, J.A. Reig, V. Cena, B. Soria, M. Prentki, and E. Roche Mitochondrial dysfunction is involved in apoptosis induced by serum withdrawal and fatty acids in the beta-cell line INS-1 Endocrinology 144 2003 335 345 (Pubitemid 36076123)
42. M. Aviram, M. Rosenblat, A. Etzioni, and R. Levy Activation of NADPH oxidase required for macrophage-mediated oxidation of low-density lipoprotein Metabolism 45 1996 1069 1079 (Pubitemid 26300305)
43. D.I. Draganov, and B.N. La Du Pharmacogenetics of paraoxonases: a brief review Naunyn Schmiedebergs Arch. Pharmacol. 369 2004 78 88 (Pubitemid 38161225)
44. M. Rosenblat, L. Gaidukov, O. Khersonsky, J. Vaya, R. Oren, D.S. Tawfik, and M. Aviram The catalytic histidine dyad of high density lipoprotein- associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux J. Biol. Chem. 281 2006 7657 7665 (Pubitemid 43847536)